( July 10, 2026, 1:46 PM EDT) -- WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on July 9 upheld a U.S. Patent Trial and Appeal Board (PTAB) decision affirming an examiner’s rejection of a claim of a medical technology company’s patent describing a blood sample collection device; the panel agreed with the finding that prior art anticipated the claim, rendering it unpatentable....